Copper(II) complexation by pituitary adenylate cyclase activating polypeptide fragments.
Results are reported from potentiometric and spectroscopic (UV-Vis, CD, and ESR) studies of the protonation constants and Cu2+ complex stability constants of pituitary adenylate cyclase activating polypeptide fragments (HSDGI-NH2, TDSYS-NH2, RKQMAVKKYLAAVL-NH2). With HSDGI-NH2, the formation of a dimeric complex Cu2H-2L2 was found in the pH range 5-8, in which the coordination of copper(II) is glycylglycine-like, while the fourth coordination site is occupied by the imidazole N3 nitrogen atom, forming a bridge between two copper(II) ions. The formation of dimeric species does not prevent the deprotonation and coordination of the amide nitrogen, and in pH above 8 the CuH-2L complex is formed. Aspartic acid in the third position of peptide sequence stabilizes the CuH-2L species and prevents the coordination of a fourth nitrogen donor. Aspartic acid residue in the second position of TDSYS-NH2 stabilizes the CuL (2N) complex but does not prevent deprotonation and binding of the second and third peptide nitrogens to give 3N and 4N complexes at higher pH. The tetradecapeptide amide forms with copper(II) ions unusually stable 3N and 4N complexes compared to pentaalanine amide.
Kowalik-Jankowska
T
T
Faculty of Chemistry, University of Wrocław, Poland. terkow@wchuwr.chem.uni.wroc.pl
Jasionowski
M
M
Lankiewicz
L
L
D000595:Amino Acid Sequence; D002942:Circular Dichroism; D003300:Copper / Q000737:chemistry*; D004355:Drug Stability; D004578:Electron Spin Resonance Spectroscopy; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D009479:Neuropeptides / Q000737:chemistry*; D010446:Peptide Fragments / Q000737:chemistry; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D011199:Potentiometry; D013053:Spectrophotometry; D013056:Spectrophotometry, Ultraviolet
D009479:Neuropeptides; D010446:Peptide Fragments; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D003300:Copper